Electronic Letters to:

Medicines information:
Allison Donnelly and Carol Paton
Safety of selective serotonin reuptake inhibitors in pregnancy
Psychiatr Bull 2007; 31: 183-186 [Abstract] [Full text] [PDF]
*eLetters: Submit a response to this article

Electronic letters published:

[Read eLetter] NICE have published antenatal and postnatal mental health guideline
Rachel Burbeck, Steve Pilling   (16 May 2007)

NICE have published antenatal and postnatal mental health guideline 16 May 2007
Top
Rachel Burbeck,
Systematic Reviewer
National Collaborating Centre for Mental Health,
Steve Pilling

Send letter to journal:
Re: NICE have published antenatal and postnatal mental health guideline

rachel.burbeck{at}ucl.ac.uk Rachel Burbeck, et al.

In response to Donnelly and Paton's article on the current state of knowledge on the safety of antidepressants during pregnancy, we would like to point out that earlier this year NICE published a guideline on antenatal and postnatal mental health, which deals with the issues raised. For example, the guideline recommends that where treatment with paroxetine is normally recommended (such as in the treatment of depression, GAD or OCD) a safer drug be considered instead. It also covers the safety of other psychotropic medication, including tricyclic antidepressants, valproate, lithium, and antipsychotics, and makes specific recommendations regarding discussing treatment plans with women who are planning a pregnancy, or already pregnant or breastfeeding. See www.nice.org.uk/CG45 for more information.